Science Explorer Back to mapMap
Discussion
Researcher · Abbott Fund · United States

Donald J. Osterling

Donald J. Osterling publishes mostly in Molecular Biology, Oncology and Cancer Research, on topics such as Cancer, Hypoxia, and Metabolism, PARP inhibition in cancer therapy and Microtubule and mitosis dynamics.

OpenAlex
World rank
#1,005,327
of 7,710,434 ranked researchers
Rank in United States
#328,057
of 1,627,098
Works
36
Citations
1.9k
Citations per work
52.1
h-index
19
i10-index 20Top 36% in Molecular Biology
Donald J. Osterling

What does Donald J. Osterling research?

Donald J. Osterling's work is mostly in Biochemistry, Genetics and Molecular Biology (45%), Medicine (23%), Pharmacology, Toxicology and Pharmaceutics (7%).

Life Sciences: 19 works · 51.6% of their workBiochemistry, Genetics and Molecular Biology: 16 works · 44.9% of their workMolecular Biology: 12 works · 32.6% of their workCancer Research: 2 works · 6.7% of their workCell Biology: 2 works · 5.6% of their workPharmacology, Toxicology and Pharmaceutics: 2 works · 6.7% of their workPharmaceutical Science: 2 works · 6.7% of their workEverything else: 9 works · 25.9% of their workHealth Sciences: 8 works · 22.5% of their workMedicine: 8 works · 22.5% of their workOncology: 6 works · 16.9% of their workHematology: 2 works · 5.6% of their workTHEIR WORKDonald J.Osterling36works
Life Sciences52%Health Sciences23%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1644.9%
    2. Pharmacology, Toxicology and Pharmaceutics26.7%
  2. Everything else925.9%
    1. Medicine822.5%
  1. 1Molecular Biology33% of their works
  2. 2Oncology17% of their works
  3. 3Cancer Research7% of their works
  4. 4Pharmaceutical Science7% of their works
  5. 5Cell Biology6% of their works
  6. 6Hematology6% of their works

Research topics

Which keywords describe Donald J. Osterling's research?

The keywords of their largest research topics: Cancer Therapy, Cancer, Homologous Recombination, Metabolism, BRCA Mutation, HIF-1, PARP Inhibitors and Warburg Effect.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Cancer Therapy153 topics
  2. Cancer143 topics
  3. Homologous Recombination102 topics
  4. Metabolism102 topics
  5. BRCA Mutation61 topic
  6. HIF-161 topic
  7. PARP Inhibitors61 topic
  8. Warburg Effect61 topic
  9. Cell Division51 topic
  10. IGF-151 topic
  11. Insulin-like Growth Factors51 topic
  12. Microtubules51 topic
  13. Signaling51 topic
  14. mTOR51 topic
  15. Cell Cycle41 topic
  16. Cyclodextrins41 topic
  17. DNA Damage41 topic
  18. Repair41 topic
  19. Solid Dispersions41 topic
  20. p5341 topic

Where does Donald J. Osterling work?

Donald J. Osterling's main affiliation in the publication record is Abbott Fund, United States.

How many publications and citations does Donald J. Osterling have?

OpenAlex counts 36 works and 1,877 citations for Donald J. Osterling, an h-index of 19, ranking #1,005,327 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Donald J. Osterling. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.